Showing posts with label Vectren Corp. Show all posts
Showing posts with label Vectren Corp. Show all posts

Tuesday, May 10, 2011

Coverage on (TRGP) (VIVO) (VRX) (VVC) Initiated

Coverage on Targa Resources Investments Inc (NASDAQ: TRGP), Meridian Bioscience, Inc. (NASDAQ: VIVO), Valeant Pharmaceuticals (NYSE: VRX) and Vectren Corporation (NYSE: VVC) initiated by analysts.

Credit Suisse (NYSE:CS) initiated coverage on Targa Resources Investments Inc (TRGP). They placed a “neutral” rating on the company.

Sidoti initiated coverage on Meridian Bioscience, Inc. (VIVO). They placed a “neutral” rating and a price target of $25.00 on the company.

Goldman Sachs (NYSE:GS) initiated coverage on Valeant Pharmaceuticals (VRX). They placed a “neutral” rating and a price target of $50.00 on the company.

Wells Fargo & Co. (NYSE:WFC) initiated coverage on Vectren Corporation (VVC). They placed a “market perform” rating on the company.